Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Clearmind Medicine
CMND
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$1.68
0.34
25.37%
At Close: -
$1.85
0.17
10.12%
After Hours: 7:59 PM EDT
15 minutes delayed
Get Report
Watch
Clearmind Medicine (CMND) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Clearmind Medicine (NASDAQ:CMND) Stock
Clearmind Medicine Stock (NASDAQ: CMND)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 28, 2024
Clearmind Medicine Granted Patent Approval In...
Benzinga Newsdesk
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher
Erica Kollmann
Clearmind Medicine shares are trading higher ...
Benzinga Newsdesk
Clearmind Medicine Granted Patent Approval In...
Benzinga Newsdesk
Thursday, June 20, 2024
Clearmind Medicine shares are trading higher ...
Benzinga Newsdesk
Clearmind Medicine Signs Exclusive Patent Lic...
Benzinga Newsdesk
Tuesday, June 11, 2024
What's Going On With Clearmind Medicine Stock Tuesday?
Adam Eckert
Market-Moving News for June 11th
Benzinga Newsdesk
Clearmind Medicine shares are trading higher ...
Benzinga Newsdesk
Clearmind Medicine Announces Advancement In I...
Benzinga Newsdesk
Friday, May 10, 2024
Clearmind Medicine Advances MEAI-Based Alcoho...
Benzinga Newsdesk
Tuesday, May 07, 2024
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why Clearmind Medicine Stock Is Moving Higher
Dylan Berman
Market-Moving News for May 7th
Benzinga Newsdesk
Clearmind Medicine shares are trading higher ...
Benzinga Newsdesk
UPDATE: Agreement Provides Clearmind With Ex...
Benzinga Newsdesk
Clearmind Medicine Signs Exclusive Patent Lic...
Benzinga Newsdesk
Tuesday, April 30, 2024
Clearmind Applies To Cease Being A Reporting ...
Benzinga Newsdesk
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Clearmind Medicine Announced An Exclusive Lic...
Benzinga Newsdesk
Wednesday, April 10, 2024
Clearmind Medicine Announced That It Has File...
Benzinga Newsdesk
Tuesday, April 09, 2024
Clearmind Medicine CEO Issues Letter To Share...
Benzinga Newsdesk
Saturday, March 30, 2024
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Lara Goldstein
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Wednesday, March 27, 2024
SciSparc- Clearmind Collaboration Evolves Wit...
Benzinga Newsdesk
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, March 19, 2024
Clearmind Medicine shares are trading higher ...
Benzinga Newsdesk
Clearmind Medicine's Psychedelic Treatment Ba...
Benzinga Newsdesk
Saturday, March 16, 2024
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Wednesday, March 13, 2024
Clearmind Medicine Obtains Israeli Ministry O...
Benzinga Newsdesk
Tuesday, March 12, 2024
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
Lara Goldstein
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
Tuesday, February 27, 2024
EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
Vandana Singh
EXCLUSIVE: Clearmind Medicine Tells Benzinga ...
Benzinga Newsdesk
Friday, February 23, 2024
Clearmind Medicine Says It Received Approval ...
Benzinga Newsdesk
Wednesday, February 21, 2024
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
Patricio Liddle
Tuesday, February 20, 2024
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?
Erica Kollmann
Clearmind Medicine Submits Three Internationa...
Benzinga Newsdesk
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Monday, February 05, 2024
Clearmind Medicine Receives Patent Approval F...
Benzinga Newsdesk
Thursday, February 01, 2024
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Clearmind Medicine shares are trading higher ...
Benzinga Newsdesk
Clearmind Medicine Announces Long-Term Licens...
Benzinga Newsdesk
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Friday, January 26, 2024
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Thursday, January 25, 2024
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Show More